{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T10:27:32Z","timestamp":1781173652729,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012895","name":"Zoetis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Tick infestations can cause direct deleterious effects to dogs as a result of tick blood-feeding, and indirectly ticks can transmit disease agents that can be detrimental to the health of both dogs and humans. Six laboratory studies were conducted to support dosage selection and efficacy confirmation of a novel combination of sarolaner, moxidectin and pyrantel against four tick species that commonly infest dogs in Europe.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Two studies were conducted against <jats:italic>Dermacentor reticulatus<\/jats:italic> (one of which was a dose determination study), two against <jats:italic>Ixodes ricinus<\/jats:italic>, and one each against <jats:italic>Ixodes hexagonus<\/jats:italic> and <jats:italic>Rhipicephalus sanguineus<\/jats:italic> (<jats:italic>sensu lato<\/jats:italic>). In each study, eight purpose-bred Beagle or mix-breed dogs were randomly allocated to each treatment group and infested with 50 unfed adult ticks on Days-2, 5, 12, 19, 26 and 33. On Day 0 dogs were treated orally with placebo or the combination product. In the dose determination study, dogs received sarolaner at point dosages of 0.6\u00a0mg\/kg, 1.2\u00a0mg\/kg or 2.4\u00a0mg\/kg in combination with moxidectin and pyrantel, and in all other studies dogs received Simparica Trio\u2122 to provide minimum dosages of 1.2\u00a0mg\/kg sarolaner, 24\u00a0\u00b5g\/kg moxidectin and 5\u00a0mg\/kg pyrantel (as pamoate salt). Efficacy was assessed based on live tick counts conducted 48\u00a0hours after treatment and each weekly infestation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There were no treatment-related adverse events in any study. In the dose determination study, 1.2\u00a0mg\/kg sarolaner was the lowest dosage evaluated that provided &gt;\u200990% efficacy for at least 28\u00a0days and therefore was selected as the dosage to provide tick control for at least one month following a single oral treatment. In the dose confirmation studies, a single oral dose of Simparica Trio\u2122 provided \u2265\u200999.2% efficacy against existing infestations of all tick species, and against re-infestations efficacy was \u2265\u200997.2% against <jats:italic>D. reticulatus<\/jats:italic> for 28 days and against all other species for 35 days.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These studies support the sarolaner dose selected and confirm the efficacy of a single oral dose of Simparica Trio\u2122 against existing infestations and re-infestations of the common tick species infesting dogs in Europe for at least one month.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13071-020-3949-y","type":"journal-article","created":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:03:04Z","timestamp":1583020984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Efficacy of a novel chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio\u2122) against four common tick species infesting dogs in Europe"],"prefix":"10.1186","volume":"13","author":[{"given":"Csilla","family":"Becskei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Liebenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjan","family":"Thys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P.","family":"Mahabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,1]]},"reference":[{"key":"3949_CR1","unstructured":"European Scientific Counsel Companion Animal Parasites. ESCCAP guideline 3: control of ectoparasites in dogs and cats, 6th edn; 2018. https:\/\/www.esccap.org\/uploads\/docs\/mjy50wev_0720_ESCCAP_Guideline_GL3_v9_1p.pdf. Accessed 30 Jan 2020."},{"key":"3949_CR2","first-page":"2","volume":"26","author":"MW Dryden","year":"2004","unstructured":"Dryden MW, Payne PA. Biology and control of ticks infesting dogs and cats in North America. Vet Ther. 2004;26:2\u201316.","journal-title":"Vet Ther."},{"key":"3949_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S1471-4922(00)01856-0","volume":"17","author":"SE Shaw","year":"2001","unstructured":"Shaw SE, Day MJ, Birtles RJ, Breitschwerdt EB. Tick-borne infectious diseases of dogs. Trends Parasitol. 2001;17:74\u201380.","journal-title":"Trends Parasitol."},{"key":"3949_CR4","unstructured":"European Scientific Counsel Companion Animal Parasites. ESCCAP guideline 5: control of vector-borne diseases in dogs and cats, 3rd edn; 2019. https:\/\/www.esccap.org\/uploads\/docs\/znkh6j1d_0775_ESCCAP_Guideline_GL5_v8_1p.pdf. Accessed 30 Jan 2020."},{"key":"3949_CR5","unstructured":"European Scientific Counsel Companion Animal Parasites. ESCCAP Guideline 01: Worm control in dogs and cats, 3rd edn; 2017. https:\/\/www.esccap.org\/uploads\/docs\/0x0o7jda_ESCCAP_Guideline_01_Third_Edition_July_2017.pdf. Accessed 12 Apr 2019."},{"key":"3949_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.vetpar.2016.02.016","volume":"222","author":"TL McTier","year":"2016","unstructured":"McTier TL, Six RH, Fourie JJ, Pullins A, Hedges L, Mahabir SP, et al. Determination of the effective dose of a novel oral formulation of sarolaner (Simparica\u2122) for the treatment and month-long control of fleas and ticks on dogs. Vet Parasitol. 2016;222:12\u20137.","journal-title":"Vet Parasitol."},{"key":"3949_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.vetpar.2016.03.024","volume":"222","author":"T Geurden","year":"2016","unstructured":"Geurden T, Becskei C, Grace S, Strube C, Doherty P, Liebenberg J, et al. Efficacy of a novel oral formulation of sarolaner (Simparica\u2122) against four common tick species infesting dogs in Europe. Vet Parasitol. 2016;222:33\u20136.","journal-title":"Vet Parasitol."},{"key":"3949_CR8","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.vetpar.2013.02.003","volume":"194","author":"AA Marchiondo","year":"2013","unstructured":"Marchiondo AA, Holdsworth PA, Fourie LJ, Rugg D, Hellmann K, Snyder DE, et al. Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) second edition: guidelines for evaluating the efficacy of parasiticides for the treatment, prevention and control of flea and tick infestations on dogs and cats. Vet Parasitol. 2013;194:84\u201397.","journal-title":"Vet Parasitol."},{"key":"3949_CR9","unstructured":"European Medicine Agency. Guideline for the testing and evaluation of the efficacy of antiparasitic substances for the treatment and prevention of tick and flea infestation in dogs and cats. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-testing-evaluation-efficacy-antiparasitic-substances-treatment-prevention-tick-flea_en-0.pdf. Accessed 12 Sept 2019."},{"key":"3949_CR10","unstructured":"European Medicines Agency. Guideline on good clinical practice. VICH Topic GL9. http:\/\/www.ema.europa.eu\/docs\/enGB\/documentlibrary\/Scientificguideline\/2009\/10\/WC500004343.pdf. Accessed 12 Apr 2019."},{"key":"3949_CR11","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.vetpar.2014.02.017","volume":"201","author":"P Dumont","year":"2014","unstructured":"Dumont P, Blair J, Fourie JJ, Chester TS, Larsen DL. Evaluation of the efficacy of afoxolaner against two European dog tick species: Dermacentor reticulatus and Ixodes ricinus. Vet Parasitol. 2014;201:216\u20139.","journal-title":"Vet Parasitol."},{"key":"3949_CR12","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.vetpar.2014.02.018","volume":"201","author":"B Kunkle","year":"2014","unstructured":"Kunkle B, Daly S, Dumont P, Drag M, Larsen D. Assessment of the efficacy of orally administered afoxolaner against Rhipicephalus sanguineus sensu lato. Vet Parasitol. 2014;201:226\u20138.","journal-title":"Vet Parasitol."},{"key":"3949_CR13","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1186\/s13071-017-2477-x","volume":"10","author":"D Cavalleri","year":"2017","unstructured":"Cavalleri D, Murphy M, Lizundia Gorbea R, Seewald W, Drake J, Nanchen S. Laboratory evaluations of the immediate and sustained effectiveness of lotilaner (Credelio\u2122) against three common species of ticks affecting dogs in Europe. Parasit Vectors. 2017;10:527.","journal-title":"Parasit Vectors."},{"key":"3949_CR14","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1046\/j.1365-2915.2000.00244.x","volume":"14","author":"NH Ogden","year":"2000","unstructured":"Ogden NH, Cripps P, Davison CC, Owen G, Parry JM, Timms BJ, et al. The ixodid tick species attaching to domestic dogs and cats in Great Britain and Ireland. Med Vet Entomol. 2000;14:332\u20138.","journal-title":"Med Vet Entomol."},{"key":"3949_CR15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/1756-3305-6-183","volume":"6","author":"E Claerebout","year":"2013","unstructured":"Claerebout E, Losson B, Cochez C, Casaert S, Dalemans AC, De Cat A, et al. Ticks and associated pathogens collected from dogs and cats in Belgium. Parasit Vectors. 2013;6:183.","journal-title":"Parasit Vectors."},{"key":"3949_CR16","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ttbdis.2013.12.009","volume":"5","author":"S Beck","year":"2014","unstructured":"Beck S, Schreiber C, Schein E, Kr\u00fccken J, Baldermann C, Pachnicke S, et al. Tick infestation and prophylaxis of dogs in northeastern Germany: a prospective study. Ticks Tick Borne Dis. 2014;5:336\u201342.","journal-title":"Ticks Tick Borne Dis."},{"key":"3949_CR17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/s13071-016-1673-4","volume":"9","author":"S Abdullah","year":"2016","unstructured":"Abdullah S, Helps C, Tasker S, Newbury H, Wall R. Ticks infesting domestic dogs in the UK: a large-scale surveillance programme. Parasit Vectors. 2016;9:391.","journal-title":"Parasit Vectors."},{"key":"3949_CR18","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1186\/s13071-014-0535-1","volume":"7","author":"C Schreiber","year":"2014","unstructured":"Schreiber C, Kr\u00fccken J, Beck S, Maaz D, Pachnicke S, Krieger K, et al. Pathogens in ticks collected from dogs in Berlin\/Brandenburg, Germany. Parasit Vectors. 2014;7:535.","journal-title":"Parasit Vectors."},{"key":"3949_CR19","doi-asserted-by":"publisher","first-page":"59232","DOI":"10.1155\/2009\/593232","volume":"2009","author":"JS Gray","year":"2009","unstructured":"Gray JS, Dautel H, Estrada-Pe\u00f1a A, Kahl O, Lindgren E. Effects of climate change on ticks and tick-borne diseases in Europe. Interdiscip Perspect Infect Dis. 2009;2009:59232.","journal-title":"Interdiscip Perspect Infect Dis."},{"key":"3949_CR20","first-page":"742","volume":"25","author":"L Kidd","year":"2003","unstructured":"Kidd L, Breitschwerdt EB. Transmission times and prevention of tick-borne diseases in dogs. Compend Contin Educ Pract Vet. 2003;25:742\u201351.","journal-title":"Compend Contin Educ Pract Vet."},{"key":"3949_CR21","unstructured":"Little SE. Changing paradigms in understanding transmission of canine tick-borne diseases: the role of interrupted feeding and intrastadial transmission. In: 2nd Canine Vector-Borne Disease (CVBD) Symposium, Mezara del Vallo, Sicily, Italy; 2007. p. 30\u20134."},{"key":"3949_CR22","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/MAJ.0b013e3181e93817","volume":"340","author":"LJ Salinas","year":"2010","unstructured":"Salinas LJ, Greenfield RA, Little SE, Voskuhl GW. Tickborne infections in the southern United States. Am J Med Sci. 2010;340:194\u2013201.","journal-title":"Am J Med Sci."},{"key":"3949_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-020-3944-3","author":"K Kryda","year":"2020","unstructured":"Kryda K, Becskei C, Mahabir SP, Carter L, Everett WR, Young DR, et al. Laboratory studies evaluating the efficacy of a novel orally administered combination product containing sarolaner, moxidectin and pyrantel (Simparica Trio\u2122) for the treatment and control of flea infestations on dogs. Parasit Vectors. 2020. https:\/\/doi.org\/10.1186\/s13071-020-3944-3.","journal-title":"Parasit Vectors"},{"key":"3949_CR24","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1186\/s13071-019-3702-6","volume":"12","author":"K Kryda","year":"2019","unstructured":"Kryda K, Six RH, Walsh KF, Holzmer SJ, Chapin S, Mahabir SP, et al. Laboratory and field studies to investigate the efficacy of a novel, orally administered combination product containing sarolaner, moxidectin and pyrantel for the prevention of heartworm disease (Dirofilaria immitis) in dogs. Parasit Vectors. 2019;12:445.","journal-title":"Parasit Vectors."},{"key":"3949_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-020-3948-z","author":"C Becskei","year":"2020","unstructured":"Becskei C, Thys M, Doherty P, Mahabir SP. Efficacy of orally administered combination of moxidectin, sarolaner and pyrantel (Simparica Trio\u2122) for the prevention of experimental Angiostrongylus vasorum infection in dogs. Parasit Vectors. 2020. https:\/\/doi.org\/10.1186\/s13071-020-3948-z.","journal-title":"Parasit Vectors."},{"key":"3949_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-020-3950-5","author":"C Becskei","year":"2020","unstructured":"Becskei C, Kryda K, Thys M, Holzmer S, Bowersock L, Fernandes T, et al. Efficacy of a new oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio\u2122) against induced ascarid infections in dogs. Parasit Vectors. 2020. https:\/\/doi.org\/10.1186\/s13071-020-3950-5.","journal-title":"Parasit Vectors."},{"key":"3949_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-020-3951-4","author":"C Becskei","year":"2020","unstructured":"Becskei C, Thys M, Kryda K, Meyer L, Martorell S, Geurden T, et al. Efficacy of Simparica Trio\u2122, a novel chewable tablet containing sarolaner, moxidectin and pyrantel, against induced hookworm infections in dogs. Parasit Vectors. 2020. https:\/\/doi.org\/10.1186\/s13071-020-3951-4.","journal-title":"Parasit Vectors."}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-020-3949-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13071-020-3949-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-020-3949-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:05:55Z","timestamp":1614557155000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-020-3949-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3949"],"URL":"https:\/\/doi.org\/10.1186\/s13071-020-3949-y","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,1]]},"assertion":[{"value":"19 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocols were reviewed and approved by the study site Institutional Animal Care and Use Committee prior to implementation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This study was funded by Zoetis, Parsippany, NJ, USA. CB, MT and SPM were employees of Zoetis. JL was a contracted study investigator.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}